Abiopharma

🔍 Chang Tina M (Executive)

Company: WEYCO GROUP INC (WEYS)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 1,265 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: A | equity_swap_involved: 0 | shares_owned_after: 20,833.00 | transaction_form_type: 4
• Holds 3,500 shares of Stock Option at $23.38 per share (Derivative)
  Date: 2026-08-25 | Code: H | Expires: 2029-08-14 | Exercise: 2020-08-14 | shares_owned_after: 3,500.00 | Footnotes: F1
• Holds 3,500 shares of Stock Option at $18.0 per share (Derivative)
  Date: 2026-08-25 | Code: H | Expires: 2030-08-26 | Exercise: 2021-08-26 | shares_owned_after: 3,500.00 | Footnotes: F2
• Holds 3,500 shares of Stock Option at $24.0 per share (Derivative)
  Date: 2026-08-25 | Code: H | Expires: 2031-08-25 | Exercise: 2022-08-25 | shares_owned_after: 3,500.00 | Footnotes: F3
• Holds 3,500 shares of Stock Option at $28.83 per share (Derivative)
  Date: 2026-08-25 | Code: H | Expires: 2032-08-25 | Exercise: 2023-08-25 | shares_owned_after: 3,500.00 | Footnotes: F4
• Holds 3,500 shares of Stock Option at $25.79 per share (Derivative)
  Date: 2026-08-25 | Code: H | Expires: 2033-08-25 | Exercise: 2024-08-25 | shares_owned_after: 3,500.00 | Footnotes: F5

Footnotes:

• F1: 20% per year for 5 years beginning 08/14/2020
• F2: 20% per year for 5 years beginning 08/26/2021
• F3: 20% per year for 5 years beginning 08/25/2022
• F4: 20% per year for 5 years beginning 08/25/2023
• F5: 20% per year for 4 years beginning 08/25/2024